AGR:LSE-Assura Plc (GBX)

COMMON STOCK | REIT-Healthcare Facilities | LSE

Last Closing Price

GBX 53.60

Change

+2.75 (+5.41)%

Market Cap

GBX 1.50B

Volume

0.01B

Avg Analyst Target

GBX 77.40 (+44.40%)

Avg User Target

GBX
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


AGR Stock Forecast & Price:
Based on the Assura Plc stock forecasts from 3 analysts, the average analyst target price for Assura Plc is GBX 77.40 over the next 12 months. Assura Plc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Assura Plc is Slightly Bullish , which is based on 12 positive signals and 8 negative signals. At the last closing, Assura Plc’s stock price was GBX 53.60. Assura Plc’s stock price has changed by -6.38% over the past week, -19.28% over the past month and -25.09% over the last year.

About Assura Plc (AGR:LSE)

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health servi ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-09-30 )

Largest Industry Peers for REIT-Healthcare Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
PHP:LSE Primary Health Properties

+5.20 (+4.81%)

GBX1.52B 10.32 N/A
THRL:LSE Target Healthcare REIT Ltd

N/A

GBX0.55B 9.91 26.25
IHR:LSE Impact Healthcare REIT PLC

N/A

GBX0.40B 8.31 N/A

ETFs Containing AGR

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (REIT-Healthcare Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -23.21% 75% C 46% F
Dividend Return 0.03% 75% C 55% F
Total Return -23.18% 75% C 46% F
Trailing 12 Months  
Capital Gain -26.37% 25% F 37% F
Dividend Return 0.04% 50% F 54% F
Total Return -26.33% 25% F 37% F
Trailing 5 Years  
Capital Gain -14.15% 50% F 38% F
Dividend Return 14.32% 67% D+ 79% C+
Total Return 0.17% 75% C 48% F
Average Annual (5 Year Horizon)  
Capital Gain 11.14% 75% C 77% C+
Dividend Return 3.06% 75% C 82% B-
Total Return 14.20% 75% C 81% B-
Risk Return Profile  
Volatility (Standard Deviation) 241.95% 50% F 8% F
Risk Adjusted Return 5.87% 25% F 46% F
Market Capitalization 1.50B 75% C 71% C-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(REIT-Healthcare Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 8.48 75% C 42% F
Price/Book Ratio 0.86 100% A+ 66% D
Price / Cash Flow Ratio 15.91 75% C 20% F
EV/EBITDA 13.92 100% A+ 18% F
Management Effectiveness  
Return on Equity 9.39% 50% F 48% F
Return on Invested Capital 4.15% 100% A+ 70% C-
Return on Assets 2.51% 25% F 45% F
Debt to Equity Ratio 69.54% 100% A+ 25% F
Technical Ratios  
Dividend Yield 5.79% 50% F 85% B
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.18 100% A+ 95% A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.